These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37734118)

  • 1. Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass.
    Gebara TSES; Felicidade I; Costa GN; de Ramos MZ; Bonde AC; Palermo G; Guemra S; Peres JHS; Mantovani MS; Napoli RPD; Campos ACL
    Nutrition; 2023 Dec; 116():112190. PubMed ID: 37734118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control.
    Schwenger KJP; Fischer SE; Jackson T; Okrainec A; Allard JP
    Surg Obes Relat Dis; 2018 Sep; 14(9):1233-1239. PubMed ID: 30049593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
    Ha Y; Hwang SG; Rim KS
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28749418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation.
    Cazzo E; de Felice Gallo F; Pareja JC; Chaim EA
    Obes Surg; 2014 Apr; 24(4):666-8. PubMed ID: 24415281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.
    Xuan Y; Wu D; Zhang Q; Yu Z; Yu J; Zhou D
    Front Endocrinol (Lausanne); 2024; 15():1457598. PubMed ID: 39253584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
    Kim MJ; Lee KJ
    BMC Pediatr; 2020 Mar; 20(1):121. PubMed ID: 32171275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
    Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
    Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between serum fructosamine and random spot urine fructose levels with the severity of non-alcoholic fatty liver disease - an analytical cross-sectional study.
    Kamuzinzi H; Kgomo M; Rheeder P; Dada N; Bester P
    S Afr Med J; 2024 May; 114(6):e1748. PubMed ID: 39041504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage.
    Zhou L; Zhang L; Zhang L; Yi W; Yu X; Mei H; Xiao H; Wang Y; Qin H; Xiong X; Yan S; Dong H; Chen P; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1224816. PubMed ID: 37720532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.
    Taranto DOL; Guimarães TCM; Couto CA; Cândido AL; Azevedo RCS; Mattos FS; Elias MLC; Reis FM; Rocha ALL; Faria LC
    Arch Endocrinol Metab; 2020; 64(3):235-242. PubMed ID: 32555989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.